IBOGAINE Act

(a) In general. Using funds allocated pursuant to subsection (c), the Secretary of Health and Human Services (in this section referred to as the Secretary), acting through the Director of the Advanced Research Projects Agency—Health, the Director of the National Institutes of Health, and the Assistant Secretary for Mental Health and Substance Use, may partner with States, territories, and Indian Tribes to implement programs to advance research on, and development of, psychedelic drugs, including ibogaine, for treating serious mental illnesses.

(b) Partnerships. A partnership under subsection (a) may include—

(1) the award of Federal funds;

(2) the provision of technical assistance; and

(3) subject to applicable privacy and other law, sharing data.